Ascendis Pharma ASASND +0.14%37 Interest Coverage is 0.37 as of Mar. 2026. GuruFocus rates ASND with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 377 Biotechnology companies, Ascendis Pharma AS ranks worse than 265251.72% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Ascendis Pharma AS's
Operating Income
for the
three
months ended in Mar. 2026 was $29 Mil. Ascendis Pharma AS's Interest Expense for the
three
months ended in Mar. 2026 was $-78 Mil.
Ascendis Pharma AS's interest coverage for the quarter that ended in Mar. 2026 was 0.37.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Ascendis Pharma AS's Interest Coverage or its related term are showing as below:
ASND's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07 * Ranked among companies with meaningful Interest Coverage only.
Ascendis Pharma AS (NAS:ASND) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Ascendis Pharma AS Interest Coverage Related Terms
Ascendis Pharma AS Interest Coverage Historical Data
* Premium members only.
The historical data trend for Ascendis Pharma AS's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ASND vs SMMT, BBIO, JAZZ: Interest Coverage Comparison
For the Biotechnology subindustry, Ascendis Pharma AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Pharma AS Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Ascendis Pharma AS's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Pharma AS (ASND) has a Interest Coverage of 0.37 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ascendis Pharma AS and its competitors. According to the industry distribution chart, Ascendis Pharma AS ranks #999999 out of 377 companies in the Biotechnology industry.
Is Ascendis Pharma AS's Interest Coverage too high?
Ascendis Pharma AS's current Interest Coverage is 0.37. The Biotechnology industry median Interest Coverage is 106.07. Ascendis Pharma AS's value of 0.37 is 99.7% below this industry median. Based on the distribution chart, Ascendis Pharma AS ranks #999999 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Interest Coverage compare to SMMT and BBIO?
According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #999999 out of 377 companies for Interest Coverage. This places Ascendis Pharma AS in the lower half of its industry. The industry median Interest Coverage is 106.07. Ascendis Pharma AS's value of 0.37 is 99.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascendis Pharma AS's current Interest Coverage of 0.37 is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ascendis Pharma AS and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascendis Pharma AS's current Interest Coverage is 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (ASND) has a current Interest Coverage of 0.37. The current Interest Coverage is 0.37 and 99.7% below the Biotechnology industry median of 106.07. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Ascendis Pharma AS (ASND), the current Interest Coverage is 0.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score
Get the complete analysis for ASND
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASND has been successfully added to your 
